4//SEC Filing
TMP Nominee II, LLC 4
Accession 0001449374-19-000024
CIK 0000764579other
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 2:14 PM ET
Size
37.9 KB
Accession
0001449374-19-000024
Insider Transaction Report
Form 4
Thomas, McNerney & Partners II, LLC
10% Owner
Transactions
- Conversion
Common Stock
2019-04-18$2.39/sh+13,881$33,162→ 43,944 total(indirect: by TMP Associates II LP) - Conversion
Series A Exchangeable Preferred Stock
2019-04-18−53,748→ 0 total→ Common Stock (3,906,315 underlying) - Conversion
Common Stock
2019-04-18$2.39/sh+24,125$57,635→ 30,063 total(indirect: by TMP Associates II LP) - Conversion
Common Stock
2019-04-18$2.39/sh+71,075$169,798→ 79,100 total(indirect: By LLC) - Conversion
Common Stock
2019-04-18$2.39/sh+40,772$97,404→ 119,872 total(indirect: By LLC) - Disposition to Issuer
Common Stock
2019-04-18$2.45/sh−12,300,186$30,135,456→ 0 total - Conversion
Series A Convertible Preferred Stock
2019-04-18−984→ 0 total(indirect: By LLC)→ Common Stock (71,075 underlying) - Conversion
Series A Exchangeable Preferred Stock
2019-04-18−191→ 0 total(indirect: by TMP Associates II LP)→ Common Stock (13,881 underlying) - Disposition to Issuer
Common Stock
2019-04-18$2.45/sh−119,872$293,686→ 0 total(indirect: By LLC) - Conversion
Series A Convertible Preferred Stock
2019-04-18−334→ 0 total(indirect: by TMP Associates II LP)→ Common Stock (24,125 underlying) - Conversion
Series A Exchangeable Preferred Stock
2019-04-18−561→ 0 total(indirect: By LLC)→ Common Stock (40,772 underlying) - Conversion
Common Stock
2019-04-18$2.39/sh+6,802,834$16,251,970→ 8,393,871 total - Conversion
Common Stock
2019-04-18$2.39/sh+3,906,315$9,332,187→ 12,300,186 total - Disposition to Issuer
Common Stock
2019-04-18$2.45/sh−43,944$107,663→ 0 total(indirect: by TMP Associates II LP) - Conversion
Series A Convertible Preferred Stock
2019-04-18−94,182→ 0 total→ Common Stock (6,802,834 underlying)
TMP Associates II LP
10% Owner
Transactions
- Conversion
Series A Exchangeable Preferred Stock
2019-04-18−53,748→ 0 total→ Common Stock (3,906,315 underlying) - Conversion
Common Stock
2019-04-18$2.39/sh+71,075$169,798→ 79,100 total(indirect: By LLC) - Conversion
Common Stock
2019-04-18$2.39/sh+40,772$97,404→ 119,872 total(indirect: By LLC) - Conversion
Series A Convertible Preferred Stock
2019-04-18−94,182→ 0 total→ Common Stock (6,802,834 underlying) - Conversion
Series A Exchangeable Preferred Stock
2019-04-18−561→ 0 total(indirect: By LLC)→ Common Stock (40,772 underlying) - Conversion
Common Stock
2019-04-18$2.39/sh+6,802,834$16,251,970→ 8,393,871 total - Conversion
Series A Convertible Preferred Stock
2019-04-18−334→ 0 total(indirect: by TMP Associates II LP)→ Common Stock (24,125 underlying) - Conversion
Common Stock
2019-04-18$2.39/sh+3,906,315$9,332,187→ 12,300,186 total - Disposition to Issuer
Common Stock
2019-04-18$2.45/sh−43,944$107,663→ 0 total(indirect: by TMP Associates II LP) - Conversion
Common Stock
2019-04-18$2.39/sh+24,125$57,635→ 30,063 total(indirect: by TMP Associates II LP) - Conversion
Common Stock
2019-04-18$2.39/sh+13,881$33,162→ 43,944 total(indirect: by TMP Associates II LP) - Disposition to Issuer
Common Stock
2019-04-18$2.45/sh−12,300,186$30,135,456→ 0 total - Disposition to Issuer
Common Stock
2019-04-18$2.45/sh−119,872$293,686→ 0 total(indirect: By LLC) - Conversion
Series A Exchangeable Preferred Stock
2019-04-18−191→ 0 total(indirect: by TMP Associates II LP)→ Common Stock (13,881 underlying) - Conversion
Series A Convertible Preferred Stock
2019-04-18−984→ 0 total(indirect: By LLC)→ Common Stock (71,075 underlying)
TMP Nominee II, LLC
10% Owner
Transactions
- Conversion
Common Stock
2019-04-18$2.39/sh+24,125$57,635→ 30,063 total(indirect: by TMP Associates II LP) - Conversion
Common Stock
2019-04-18$2.39/sh+3,906,315$9,332,187→ 12,300,186 total - Conversion
Common Stock
2019-04-18$2.39/sh+71,075$169,798→ 79,100 total(indirect: By LLC) - Conversion
Common Stock
2019-04-18$2.39/sh+6,802,834$16,251,970→ 8,393,871 total - Conversion
Common Stock
2019-04-18$2.39/sh+13,881$33,162→ 43,944 total(indirect: by TMP Associates II LP) - Disposition to Issuer
Common Stock
2019-04-18$2.45/sh−12,300,186$30,135,456→ 0 total - Disposition to Issuer
Common Stock
2019-04-18$2.45/sh−43,944$107,663→ 0 total(indirect: by TMP Associates II LP) - Conversion
Series A Convertible Preferred Stock
2019-04-18−94,182→ 0 total→ Common Stock (6,802,834 underlying) - Conversion
Series A Exchangeable Preferred Stock
2019-04-18−191→ 0 total(indirect: by TMP Associates II LP)→ Common Stock (13,881 underlying) - Conversion
Common Stock
2019-04-18$2.39/sh+40,772$97,404→ 119,872 total(indirect: By LLC) - Disposition to Issuer
Common Stock
2019-04-18$2.45/sh−119,872$293,686→ 0 total(indirect: By LLC) - Conversion
Series A Convertible Preferred Stock
2019-04-18−334→ 0 total(indirect: by TMP Associates II LP)→ Common Stock (24,125 underlying) - Conversion
Series A Exchangeable Preferred Stock
2019-04-18−53,748→ 0 total→ Common Stock (3,906,315 underlying) - Conversion
Series A Exchangeable Preferred Stock
2019-04-18−561→ 0 total(indirect: By LLC)→ Common Stock (40,772 underlying) - Conversion
Series A Convertible Preferred Stock
2019-04-18−984→ 0 total(indirect: By LLC)→ Common Stock (71,075 underlying)
Thomas, McNerney & Partners II L.P.
10% Owner
Transactions
- Conversion
Common Stock
2019-04-18$2.39/sh+71,075$169,798→ 79,100 total(indirect: By LLC) - Conversion
Common Stock
2019-04-18$2.39/sh+40,772$97,404→ 119,872 total(indirect: By LLC) - Disposition to Issuer
Common Stock
2019-04-18$2.45/sh−43,944$107,663→ 0 total(indirect: by TMP Associates II LP) - Conversion
Series A Convertible Preferred Stock
2019-04-18−94,182→ 0 total→ Common Stock (6,802,834 underlying) - Conversion
Series A Convertible Preferred Stock
2019-04-18−984→ 0 total(indirect: By LLC)→ Common Stock (71,075 underlying) - Conversion
Series A Exchangeable Preferred Stock
2019-04-18−53,748→ 0 total→ Common Stock (3,906,315 underlying) - Conversion
Series A Exchangeable Preferred Stock
2019-04-18−191→ 0 total(indirect: by TMP Associates II LP)→ Common Stock (13,881 underlying) - Conversion
Common Stock
2019-04-18$2.39/sh+6,802,834$16,251,970→ 8,393,871 total - Conversion
Common Stock
2019-04-18$2.39/sh+24,125$57,635→ 30,063 total(indirect: by TMP Associates II LP) - Conversion
Common Stock
2019-04-18$2.39/sh+13,881$33,162→ 43,944 total(indirect: by TMP Associates II LP) - Disposition to Issuer
Common Stock
2019-04-18$2.45/sh−119,872$293,686→ 0 total(indirect: By LLC) - Conversion
Series A Convertible Preferred Stock
2019-04-18−334→ 0 total(indirect: by TMP Associates II LP)→ Common Stock (24,125 underlying) - Conversion
Series A Exchangeable Preferred Stock
2019-04-18−561→ 0 total(indirect: By LLC)→ Common Stock (40,772 underlying) - Conversion
Common Stock
2019-04-18$2.39/sh+3,906,315$9,332,187→ 12,300,186 total - Disposition to Issuer
Common Stock
2019-04-18$2.45/sh−12,300,186$30,135,456→ 0 total
Footnotes (7)
- [F1]The reporting person converted 94,182 shares of Series A Convertible Preferred Stock on April 18, 2019, resulting in its acquisition of 6,802,834 shares of common stock. The Series A Convertible Preferred Stock was convertible into common stock at any time by converting the accreted value thereof into common stock at a conversion price of $2.389 per share, and had no expiration date.
- [F2]The reporting person converted 334 shares of Series A Convertible Preferred Stock on April 18, 2019, resulting in its acquisition of 24,125 shares of common stock. The Series A Convertible Preferred Stock was convertible into common stock at any time by converting the accreted value thereof into common stock at a conversion price of $2.389 per share, and had no expiration date.
- [F3]The reporting person converted 984 shares of Series A Convertible Preferred Stock on April 18, 2019, resulting in its acquisition of 71,075 shares of common stock. The Series A Convertible Preferred Stock was convertible into common stock at any time by converting the accreted value thereof into common stock at a conversion price of $2.389 per share, and had no expiration date.
- [F4]The reporting person converted 53,748 shares of Series A Exchangeable Preferred Stock on April 18, 2019, resulting in its acquisition of 3,906,315 shares of common stock. The Series A Exchangeable Preferred Stock was convertible into common stock at any time by converting the accreted value thereof into common stock at a conversion price of $2.389 per share, and had no expiration date.
- [F5]The reporting person converted 191 shares of Series A Exchangeable Preferred Stock on April 18, 2019, resulting in its acquisition of 13,881 shares of common stock. The Series A Exchangeable Preferred Stock was convertible into common stock at any time by converting the accreted value thereof into common stock at a conversion price of $2.389 per share, and had no expiration date.
- [F6]The reporting person converted 561 shares of Series A Exchangeable Preferred Stock on April 18, 2019, resulting in its acquisition of 40,772 shares of common stock. The Series A Exchangeable Preferred Stock was convertible into common stock at any time by converting the accreted value thereof into common stock at a conversion price of $2.389 per share, and had no expiration date.
- [F7]Each issued and outstanding share of common stock was, as a result of the consummation of the merger contemplated by the Agreement and Merger by and among CAS Medical Systems, Inc., Edwards Lifesciences Holding, Inc. and Crown Merger Sub, Inc., dated as of February 11, 2019 (the "Merger Agreement"), canceled in exchange for the right to receive a per share amount equal to $2.45 in cash without interest.
Documents
Issuer
CAS MEDICAL SYSTEMS INC
CIK 0000764579
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001436054
Filing Metadata
- Form type
- 4
- Filed
- Apr 21, 8:00 PM ET
- Accepted
- Apr 22, 2:14 PM ET
- Size
- 37.9 KB